Project Number 5P01AG003991-37 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 3. Traditional assessments Researcher and Organization Principal Investigator LUCEY, BRENDAN PATRICK Principal Investigator First Name BRENDAN Principal Investigator Last Name LUCEY Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-297: NIA Program Project Applications (P01 Clinical Trial Optional) FY Overall Cost $203,288 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official HSIAO, JOHN Related Resources Repository [NIAGADS] SORL1 coding variants and risk for AD [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] CSF Summary Statistics [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011)
